Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders
Jacob M. Haus, John P. Thyfault
Jacob M. Haus, John P. Thyfault
Published October 22, 2018
Citation Information: J Clin Invest. 2018;128(12):5198-5200. https://doi.org/10.1172/JCI124304.
View: Text | PDF
Commentary Article has an altmetric score of 1

Therapeutic potential of carbonyl-scavenging carnosine derivative in metabolic disorders

  • Text
  • PDF
Abstract

Obesity and overnutrition increase levels of reactive sugar- and lipid-derived aldehydes called reactive carbonyl species (RCS). Increased tissue and circulating RCS levels have been tied to insulin resistance and inflammation, but previous pharmacological approaches to target RCS have had equivocal outcomes. In this issue of the JCI, Anderson et al. present evidence for the development and implementation of carnisonol, a compound that is biologically stable in vivo and shows impressive effects on improving metabolism and inflammation in rodent models of diet-induced obesity and metabolic dysfunction.

Authors

Jacob M. Haus, John P. Thyfault

×

Total citations by year

Year: 2023 2022 2021 2020 2019 Total
Citations: 2 2 2 3 1 10
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (10)

Title and authors Publication Year
Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment
Cesak O, Vostalova J, Vidlar A, Bastlova P, Student V Jr
Nutrients 2023
LC/MS analysis of mushrooms provided new insights into dietary management of diabetes mellitus in rats
Hussein A, Ghonimy A, Jiang H, Qin G, El\u2010Ashram S, Hussein S, Abd El\u2010Razek I, El\u2010Afifi T, Farouk MH
Food Science & Nutrition 2023
Food-Related Carbonyl Stress in Cardiometabolic and Cancer Risk Linked to Unhealthy Modern Diet
C Iacobini, M Vitale, J Haxhi, C Pesce, G Pugliese, S Menini
Nutrients 2022
Oxidative Stress and Redox Signaling in the Pathophysiology of Liver Diseases
Mooli RG, Mukhi D, Ramakrishnan SK
Comprehensive Physiology 2022
Carnosine quenches the reactive carbonyl acrolein in the central nervous system and attenuates autoimmune neuroinflammation
J Spaas, WM Franssen, C Keytsman, L Blancquaert, T Vanmierlo, J Bogie, B Broux, N Hellings, J van Horssen, DK Posa, D Hoetker, SP Baba, W Derave, BO Eijnde
Journal of Neuroinflammation 2021
Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress
S Menini, C Iacobini, M Vitale, C Pesce, G Pugliese
Cancers 2021
A Comprehensive Review on Source, Types, Effects, Nanotechnology, Detection, and Therapeutic Management of Reactive Carbonyl Species Associated with Various Chronic Diseases
S Fuloria, V Subramaniyan, S Karupiah, U Kumari, K Sathasivam, DU Meenakshi, YS Wu, RM Guad, K Udupa, NK Fuloria
Antioxidants 2020
Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in KrasG12D/+ mice
S Menini, C Iacobini, L de Latouliere, I Manni, M Vitale, E Pilozzi, C Pesce, P Cappello, F Novelli, G Piaggio, G Pugliese
Journal of Experimental & Clinical Cancer Research 2020
Wedelolactone Mitigates Parkinsonism Via Alleviating Oxidative Stress and Mitochondrial Dysfunction Through NRF2/SKN-1
S Sharma, S Trivedi, T Pandey, S Ranjan, M Trivedi, R Pandey
Molecular Neurobiology 2020
Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye
M Baydyuk, DS Cha, J Hu, R Yamazaki, EM Miller, VN Smith, KA Kelly, JK Huang
Proceedings of the National Academy of Sciences 2019

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Posted by 1 X users
On 1 Facebook pages
13 readers on Mendeley
See more details